AU:OSL Stock Latest News
Company AnnouncementsOncoSil boosts real-world evidence as OSPREY registry expands in Europe4d agoOSL
Company AnnouncementsOncoSil Medical Sets November Date for Virtual AGM, Urges Early Proxy Voting6d agoOSL
Company AnnouncementsOncoSil joins EU-backed PALACROS trial in capital-efficient push into pancreatic cancer research1w agoOSL
Company AnnouncementsOncoSil sets 2026 AGM date and director nomination deadline3w agoOSL
Company AnnouncementsOncoSil Medical to Release 41,067 Escrowed Shares as Global Oncology Push Continues1M agoOSL
Company AnnouncementsOncoSil raises $4m in compliant share placement to support global oncology push1M agoOSL
Company AnnouncementsOncoSil Secures Key ISO Step Toward Scaling Production of Cancer Device1M agoOSL- Company AnnouncementsOncoSil hits 100-patient milestone in key Spanish cancer market1M agoOSL
Company AnnouncementsOncoSil Medical Plans ASX Share Placement to Raise Capital1M agoOSL
Company AnnouncementsOncoSil Medical Raises $5.6m to Drive Cancer Device Commercialisation1M agoOSL
Company AnnouncementsOncoSil Seeks CMS Pass-Through Status to Support U.S. Launch of Cancer Device1M agoOSLCompany AnnouncementsOncoSil Seeks US Medicare Pass-Through Status for Targeted Cancer Device1M agoOSL
- Company AnnouncementsOncoSil narrows annual loss as revenue and other income surge1M agoOSL
- Company AnnouncementsOncoSil Seeks ASX Quotation for Small Issue of New Shares2M agoOSL
- Company AnnouncementsOncoSil Flags FDA Milestone While Stressing Investor Caution2M agoOSL
- Company AnnouncementsOncoSil Wins Landmark U.S. FDA Approval for Rare Bile Duct Cancer Device2M agoOSL
Company AnnouncementsOncoSil Study Backs Higher-Concentration Formulations to Boost Efficiency3M agoOSL
